XML 115 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Notes to the consolidated financial statements - Grants with government agencies and similar bodies (Details) € in Thousands, $ in Thousands, item in Millions	1 Months Ended												12 Months Ended				24 Months Ended
	Oct. 31, 2021 EUR (€)	Dec. 31, 2020 EUR (€)	Dec. 31, 2020 USD ($)	Nov. 30, 2020 EUR (€) item	Nov. 30, 2020 USD ($) item	Aug. 31, 2019 EUR (€)	Aug. 31, 2019 USD ($)	Feb. 28, 2019 USD ($)	Nov. 30, 2017 EUR (€)	Nov. 30, 2017 USD ($)	Nov. 30, 2016 EUR (€)	Nov. 30, 2016 USD ($)	Dec. 31, 2023 EUR (€)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 EUR (€)	Dec. 31, 2021 EUR (€)	Dec. 31, 2021 EUR (€)	Jul. 31, 2020 EUR (€)	May 31, 2020 USD ($)	Jan. 31, 2020 USD ($)
Notes to the consolidated financial statements
Income from release of governmental contract liabilities	€ 574,502															€ 574,502
Receipts from grants from government agencies and similar bodies																93,531
Advance Purchase Agreement with European Commission
Notes to the consolidated financial statements
Number of doses of SARS-CoV-2 advance purchase by the Member States under agreement | item				225	225
Upfront Payment Received	450,000			€ 450,000
Payment of accrued other liabilities of upfront payment													€ 4,114
Maximum grant	€ 0
Accrued other liability for up-front payment															€ 4,114
GSK
Notes to the consolidated financial statements
Compensation consist for set-up activities															20,500
Reimbursement of prepayments															12,000
German Federal Ministry of Education and Research
Notes to the consolidated financial statements
Remaining grant income																65,000
Income from release of governmental contract liabilities													0		0	65,218
Maximum grant																		€ 252,000
Milestone payment received																	€ 196,300
German Federal Ministry of Education and Research | Miscellaneous other operating income
Notes to the consolidated financial statements
Remaining grant income													3,064
Coalition for Epidemic Preparedness Innovations
Notes to the consolidated financial statements
Maximum grant | $																			$ 15,300	$ 8,300
Maximum amount under the partnership agreement | $								$ 34,000
Term of the partnership agreement								3 years
Period for which the costs are to be covered								6 months
Reimbursement of approved expenses													3		42	688
Grants received and deferred													305		309
Maximum unspent funds reimbursable | $														$ 1,000
Bill & Melinda Gates Foundation (BMGF)
Notes to the consolidated financial statements
Receipts from grants from government agencies and similar bodies											€ 614	$ 653
Number of additional grants received									2	2
Amortization of the grants																488
Repayment of grant received from government													217
Grants received and deferred													1,430
Bill & Melinda Gates Foundation (BMGF), Grant for development of a universal influenza vaccine
Notes to the consolidated financial statements
Receipts from grants from government agencies and similar bodies				280	$ 322	€ 486	$ 540		€ 852	$ 1,000
Bill & Melinda Gates Foundation (BMGF), Grant for malaria vaccine
Notes to the consolidated financial statements
Receipts from grants from government agencies and similar bodies		€ 1,208	$ 1,449	€ 1,208	$ 1,449				€ 673	$ 800
Amortization of the grants													€ 66		167
Grants received and deferred															€ 1,712
Bundesministerium fr Bildung und Forschung
Notes to the consolidated financial statements
Income from release of governmental contract liabilities																€ 124,000

X

- Definition

The amount of accrued other liability for up-front payment.

+ References

No definition available.

+ Details

Name:	cvac_AccruedOtherLiabilityForUpFrontPayment
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of amortization of the grants.

+ References

No definition available.

+ Details

Name:	cvac_AmortizationOfGovernmentGrants
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents the amount of income recognized on compensation for contract manufacturing organizations transfer which is mainly for consideration for set-up activities.

+ References

No definition available.

+ Details

Name:	cvac_CompensationForContractManufacturingOrganizationsTransferConsiderationForSetUpActivities
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Represents the amount of income recognized on compensation for contract manufacturing organizations transfer which is mainly for Manufacturing Interim Period Reimbursable Expenses.

+ References

No definition available.

+ Details

Name:	cvac_CompensationForContractManufacturingOrganizationsTransferManufacturingInterimPeriodReimbursableExpenses
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	cvac_DisclosureOfGovernmentGrantsLineItems
Namespace Prefix:	cvac_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of milestone payment received.

+ References

No definition available.

+ Details

Name:	cvac_IfrsMilestonePaymentReceived
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of remaining grant income classified as other operating income.

+ References

No definition available.

+ Details

Name:	cvac_IfrsRemainingGrantIncome
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of maximum grant receivable.

+ References

No definition available.

+ Details

Name:	cvac_MaximumGrantToBeReceived
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The amount of maximum unspent funds reimbursable.

+ References

No definition available.

+ Details

Name:	cvac_MaximumUnspentFundsReimbursable
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Number of additional grants received by the company.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfAdditionalGrantsReceived
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of doses of SARS-CoV-2 advance purchase by the Member States under agreement.

+ References

No definition available.

+ Details

Name:	cvac_NumberOfDosesOfSarsCov2CanBePurchasedByMemberStatesUnderAdvancePurchaseAgreement
Namespace Prefix:	cvac_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Maximum amount agreed under the partnership agreement.

+ References

No definition available.

+ Details

Name:	cvac_PartnershipAgreementMaximumAmount
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Period for which the costs are to be covered by the funds received under the partnership agreement.

+ References

No definition available.

+ Details

Name:	cvac_PartnershipAgreementPeriodOfCostsToBeCovered
Namespace Prefix:	cvac_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Term of the partnership agreement.

+ References

No definition available.

+ Details

Name:	cvac_PartnershipAgreementTerm
Namespace Prefix:	cvac_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of payment of accrued other liabilities of upfront payment.

+ References

No definition available.

+ Details

Name:	cvac_PaymentOfAccruedOtherLiabilitiesOfUpfrontPayment
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The cash inflow from government grants and similar bodies.

+ References

No definition available.

+ Details

Name:	cvac_ReceiptsFromGovernmentGrantsClassifiedAsOperatingActivities
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of reimbursement of approved expenses

+ References

No definition available.

+ Details

Name:	cvac_ReimbursementOfApprovedExpenses
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The cash outflow for repayment of received government grant.

+ References

No definition available.

+ Details

Name:	cvac_RepaymentOfGrantReceivedFromGovernment
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of upfront payment received.

+ References

No definition available.

+ Details

Name:	cvac_UpfrontPaymentReceived
Namespace Prefix:	cvac_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_GovernmentGrants
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of income recognised in relation to government grants. [Refer: Government grants]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 20
-IssueDate 2023-01-01
-Paragraph 39
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_RevenueFromGovernmentGrants
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	cvac_IfrsTypeOfArrangementAxis=cvac_AdvancedPurchaseAgreementWithEuropeanCommissionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_CounterpartyNameAxis=cvac_GlaxosmithklineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_GermanFederalMinistryOfEducationAndResearchMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_IfrsIncomeStatementLocationAxis=cvac_MiscellaneousOtherOperatingIncomeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_CoalitionForEpidemicPreparednessInnovationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_BillAndMelindaGatesFoundationBmgfMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_BillMelindaGatesFoundationBmgfGrantForDevelopmentOfUniversalInfluenzaVaccineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_BillMelindaGatesFoundationBmgfGrantForMalariaVaccineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cvac_GovernmentGrantsAxis=cvac_BundesministeriumFurBildungUndForschungMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: